DOWLING & YAHNKE LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
DOWLING & YAHNKE LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$385,000
+75.0%
683,808
+1225.2%
0.05%
+65.5%
Q3 2014$220,00051,6000.03%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,229,287$9,625,00044.28%
Foresite Capital Management II, LLC 4,200,047$32,886,00019.48%
Scale Management, LLC 2,884,305$22,584,00011.28%
Cheyne Capital Management (UK) LLP 1,484,409$11,601,0002.80%
Telemetry Investments, L.L.C. 463,039$3,626,0002.00%
NEA Management Company, LLC 3,709,000$29,041,0001.31%
Rock Springs Capital Management LP 1,550,000$12,137,0001.14%
Rhenman & Partners Asset Management AB 831,800$6,513,0001.10%
Tamarack Capital Management, LLC 1,000,000$7,830,0001.03%
RA Capital Management 1,186,229$9,288,0000.92%
View complete list of OREXIGEN THERAPEUTICS INC shareholders